A detailed history of Polianta LTD transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Polianta LTD holds 3,300 shares of BIO stock, worth $1.07 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
3,300
Previous 4,100 19.51%
Holding current value
$1.07 Million
Previous $1.12 Million 1.34%
% of portfolio
0.52%
Previous 0.57%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$263.97 - $344.64 $211,176 - $275,712
-800 Reduced 19.51%
3,300 $1.1 Million
Q2 2024

Jul 05, 2024

BUY
$268.26 - $339.48 $214,608 - $271,584
800 Added 24.24%
4,100 $1.12 Million
Q1 2024

Apr 10, 2024

BUY
$304.11 - $351.99 $182,466 - $211,194
600 Added 22.22%
3,300 $1.14 Million
Q3 2023

Oct 12, 2023

BUY
$350.25 - $422.63 $945,675 - $1.14 Million
2,700 New
2,700 $967,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.02B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Polianta LTD Portfolio

Follow Polianta LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

News

Stay updated on Polianta LTD with notifications on news.